Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Axsome Therapeutics Inc (GB:0HKF)
LSE:0HKF
Axsome Therapeutics (0HKF) Stock Price & Analysis
0 Followers
0HKF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$22.05 - $81.00
Previous Close$59.24
Volume496.00
Average Volume (3M)431.00
Market Cap
$2.72B
Enterprise Value$2.53B
Total Cash (Recent Filing)$200.84M
Total Debt (Recent Filing)$94.68M
Price to Earnings (P/E)N/A
Beta0.68
Next Earnings
May 10, 2023EPS Estimate
-$1.31Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding43,516,501
10 Day Avg. Volume117
30 Day Avg. Volume431
Standard Deviation0.46
R-Squared0.12
Alpha0.16
Financial Highlights & Ratios
Price to Book (P/B)68.11
Price to Sales (P/S)60.32
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-15.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue50.54
Enterprise Value/Gross Profit56.40
Enterprise Value/Ebitda-14.51
Forecast
1Y Price Target
$103.22Price Target Upside74.25% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
Axsome Therapeutics News
0HKF FAQ
What was Axsome Therapeutics Inc’s price range in the past 12 months?
Axsome Therapeutics Inc lowest stock price was $22.05 and its highest was $81.00 in the past 12 months.
What is Axsome Therapeutics Inc’s market cap?
Currently, no data Available
When is Axsome Therapeutics Inc’s upcoming earnings report date?
Axsome Therapeutics Inc’s upcoming earnings report date is May 10, 2023 which is in 40 days.
How were Axsome Therapeutics Inc’s earnings last quarter?
Axsome Therapeutics Inc released its earnings results on Feb 27, 2023. The company reported -$1.41 earnings per share for the quarter, missing the consensus estimate of -$1.126 by -$0.284.
Is Axsome Therapeutics Inc overvalued?
According to Wall Street analysts Axsome Therapeutics Inc’s price is currently Undervalued.
Does Axsome Therapeutics Inc pay dividends?
Axsome Therapeutics Inc does not currently pay dividends.
What is Axsome Therapeutics Inc’s EPS estimate?
Axsome Therapeutics Inc’s EPS estimate is -$1.31.
How many shares outstanding does Axsome Therapeutics Inc have?
Currently, no data Available
What happened to Axsome Therapeutics Inc’s price movement after its last earnings report?
Axsome Therapeutics Inc reported an EPS of -$1.41 in its last earnings report, missing expectations of -$1.126. Following the earnings report the stock price went up 5.194%.
Which hedge fund is a major shareholder of Axsome Therapeutics Inc?
Among the largest hedge funds holding Axsome Therapeutics Inc’s share is Fairmount Funds Management Llc. It holds Axsome Therapeutics Inc’s shares valued at 155M.
---
Axsome Therapeutics Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$103.22 (74.25% Upside)
$103.22 (74.25% Upside)
Blogger Sentiment
Bullish
GB:0HKF Sentiment 92%
Sector Average 69%
Sector Average 69%
Insider Transactions
Bought Shares
Worth $22.8K over
the Last 3 Months
the Last 3 Months
News Sentiment
Positive
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
58.83%
12-Months-Change
Fundamentals
Return on Equity
-298.97%
Trailing 12-Months
Asset Growth
277.60%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Axsome Therapeutics Inc
Axsome Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies for the management of central nervous system disorders. Its product candidates include AXS-02 and AXS-06 which are developing for multiple indications. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.
---
Elanco Animal Health
―
Intra-Cellular Therapies
―
Harmony Biosciences Holdings
―
Axsome Therapeutics
―
Prestige Consumer Healthcare
―
---